LGA
BHC icon

Lebenthal Global Advisors’s Bausch Health BHC Stock Holding History

Lebenthal Global Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Buy
72,969
+13
+0% +$70 0.05% 171
2026
Q1 		$394K Sell
72,956
-7,766
-10% -$46.5K 0.06% 164
2025
Q4 		$561K Buy
80,722
+17,039
+27% +$112K 0.09% 145
2025
Q3 		$411K Buy
63,683
+551
+0.9% +$3.77K 0.07% 157
2025
Q2 		$420K Buy
63,132
+4,471
+8% +$23K 0.08% 145
2025
Q1 		$380K Buy
58,661
+13,078
+29% +$94K 0.07% 152
2024
Q4 		$367K Buy
45,583
+901
+2% +$7.43K 0.07% 154
2024
Q3 		$365K Buy
44,682
+169
+0.4% +$1.11K 0.07% 146
2024
Q2 		$310K Buy
44,513
+28
+0.1% +$212 0.07% 152
2024
Q1 		$472K Sell
44,485
-13,372
-23% -$117K 0.1% 122
2023
Q4 		$464K Buy
57,857
+8,633
+18% +$62.9K 0.11% 121
2023
Q3 		$405K Sell
49,224
-11,200
-19% -$96.6K 0.12% 90
2023
Q2 		$483K Sell
60,424
-16,353
-21% -$121K 0.14% 75
2023
Q1 		$622K Buy
76,777
+993
+1% +$7.97K 0.19% 58
2022
Q4 		$476K Buy
75,784
+32,195
+74% +$225K 0.16% 74
2022
Q3 		$300K Buy
43,589
+56
+0.1% +$389 0.14% 89
2022
Q2 		$363K Buy
43,533
+8,644
+25% +$121K 0.18% 89
2022
Q1 		$797K Buy
34,889
+9,175
+36% +$224K 0.34% 44
2021
Q4 		$709K Buy
25,714
+1,456
+6% +$39K 0.29% 45
2021
Q3 		$675K Buy
24,258
+43
+0.2% +$1.22K 0.42% 43
2021
Q2 		$710K Buy
24,215
+6,645
+38% +$201K 0.38% 42
2021
Q1 		$557K Sell
17,570
-6,305
-26% -$185K 0.34% 39
2020
Q4 		$494K Buy
+23,875
New +$445K 0.35% 33

Other funds holding BHC

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Lebenthal Global Advisors's BHC Position: Q2 2026 in Review

Lebenthal Global Advisors increased its Bausch Health (BHC) stake by 0.02% in Q2 2026, buying an estimated $70 and bringing the position to 72,969 shares worth $360K. The position accounts for 0.05% of the portfolio, ranked #171.

Lebenthal Global Advisors first reported a position in BHC in Q4 2020 and has held it in 23 quarters since. The position peaked at $797K in Q1 2022. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Lebenthal Global Advisors held 72,969 shares of Bausch Health worth $360K as of Q2 2026.
  • Lebenthal Global Advisors bought 13 Bausch Health shares in Q2 2026, an estimated $70.
  • Bausch Health made up 0.05% of Lebenthal Global Advisors's portfolio in Q2 2026, its #171 holding.
  • Lebenthal Global Advisors first reported a position in Bausch Health in Q4 2020 and has held it in 23 quarters since.
  • Lebenthal Global Advisors's Bausch Health position peaked at $797K in Q1 2022.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Lebenthal Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.